Citius Pharmaceuticals (CTXR)
Nasdaq • CTXR • US17322U3068
ORTEX Data Highlights
ORTEX Data Highlights
As of Oct 27, 2026, ORTEX estimated 21.8% of free float sold short, 22.8 days to cover, cost to borrow 26.82%. Sign up for live short interest data.
Market Cap
13.2m USD | # 10856 in US
Volume
367.05k shares | 201.51k USD
Shares Outstanding
27.45m
Free Float Shares
98.20% | 26.96m
